Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.

MLA

Wang, Hongmei, et al. “Do Angiotensin-Converting Enzyme Inhibitors Reduce the Risk of Symptomatic Radiation Pneumonitis in Patients with Non-Small Cell Lung Cancer after Definitive Radiation Therapy? Analysis of a Single-Institution Database.” International Journal of Radiation Oncology, Biology, Physics, vol. 87, no. 5, Dec. 2013, pp. 1071–77. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2013.08.033.

APA

Wang, H., Liao, Z., Zhuang, Y., Xu, T., Nguyen, Q.-N., Levy, L. B., O’Reilly, M., Gold, K. A., & Gomez, D. R. (2013). Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database. International Journal of Radiation Oncology, Biology, Physics, 87(5), 1071–1077. https://doi.org/10.1016/j.ijrobp.2013.08.033

Chicago

Wang, Hongmei, Zhongxing Liao, Yan Zhuang, Ting Xu, Quynh-Nhu Nguyen, Lawrence B Levy, Michael O’Reilly, Kathryn A Gold, and Daniel R Gomez. 2013. “Do Angiotensin-Converting Enzyme Inhibitors Reduce the Risk of Symptomatic Radiation Pneumonitis in Patients with Non-Small Cell Lung Cancer after Definitive Radiation Therapy? Analysis of a Single-Institution Database.” International Journal of Radiation Oncology, Biology, Physics 87 (5): 1071–77. doi:10.1016/j.ijrobp.2013.08.033.